INVX insider plans sale of 20,000 shares

An affiliate of INVX has filed a Form 144 giving notice of a planned sale of 20,000 shares of common stock through UBS Financial Services, Inc. on the NYSE.

Rhea-AI Filing Summary

An affiliate of INVX has filed a Form 144 giving notice of a planned sale of 20,000 shares of common stock through UBS Financial Services, Inc. on the NYSE. The filing lists an aggregate market value of $500,000 for these shares, compared with 68,927,791 shares outstanding for the issuer.

The shares to be sold were acquired as a stock award from the issuer on July 3, 2024, in a non-cash transaction described as “N/A” for payment. The approximate date of sale is indicated as January 14, 2026. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does INVX's Form 144 filing disclose?

The Form 144 filing for INVX discloses a planned sale of 20,000 shares of common stock with an aggregate market value of $500,000, to be executed through UBS Financial Services, Inc. on the NYSE.

How many INVX shares are planned to be sold and on which exchange?

The notice covers 20,000 shares of INVX common stock, with the sale expected to take place on the NYSE through UBS Financial Services, Inc..

When were the INVX shares being sold acquired and how?

The 20,000 INVX shares were acquired on July 3, 2024 as a stock award from the issuer, with the payment description listed as N/A, indicating a non-cash award.

What is the approximate date of the planned INVX share sale?

The Form 144 indicates an approximate sale date of January 14, 2026 for the 20,000 INVX common shares covered by the notice.

How many INVX shares are outstanding according to the Form 144?

The filing states that there are 68,927,791 shares of INVX common stock outstanding, providing context for the size of the planned 20,000-share sale.

What representation does the seller make in INVX's Form 144 notice?

By signing the Form 144, the seller represents that they do not know of any material adverse information about INVX’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/14/2026 - 04:07 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002025761
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innovex International, Inc.
SEC File Number	001-13439
Address of Issuer	19120 KENSWICK DRIVE HUMBLE TEXAS 77338
Phone	3463980000
Name of Person for Whose Account the Securities are To Be Sold	Reddout Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	20000	500000.00	68927791	01/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/03/2024	Stock Award	Issuer			20000	07/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Mark Reddout
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)